ArticleBlood advances2017

Glycoprotein Ibα inhibitor (CCP-224) prevents neutrophil-platelet aggregation in Sickle Cell Disease.

Maritza A Jimenez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.